DZ Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

DZ Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,734	Closed	-$805K	–	1034
2025 Q4	$805K	Hold	4,734	–	–	﹤0.01%	737
2025 Q3	$624K	Hold	4,734	–	–	﹤0.01%	752
2025 Q2	$502K	Sell	4,734 -6,359	-57%	-$691K	﹤0.01%	739
2025 Q1	$1.38M	Sell	11,093 -6,614	-37%	-$863K	﹤0.01%	635
2024 Q4	$2.18M	Sell	17,707 -8,026	-31%	-$946K	﹤0.01%	552
2024 Q3	$2.87M	Buy	25,733 +7,110	+38%	+$779K	﹤0.01%	539
2024 Q2	$1.99M	Sell	18,623 -108,665	-85%	-$11.9M	﹤0.01%	580
2024 Q1	$15.3M	Buy	127,288 +69,748	+121%	+$8.54M	0.02%	288
2023 Q4	$7.08M	Buy	+57,540	New	+$7.18M	0.01%	413
2022 Q4	–	Sell	-46,630	Closed	-$6.22M	–	1063
2022 Q3	$6.22M	Hold	46,630	–	–	0.01%	400
2022 Q2	$7.27M	Buy	+46,630	New	+$7.18M	0.01%	374
2018 Q2	–	Sell	-11,500	Closed	-$1.74M	–	966
2018 Q1	$1.74M	Buy	+11,500	New	+$1.69M	0.01%	571

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

DZ Bank's JAZZ Position: Q1 2026 in Review

DZ Bank sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 4,734 shares — an estimated $805K sold.

DZ Bank first reported a position in JAZZ in Q1 2018 and held it in 12 quarters. The position peaked at $15.3M in Q1 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

DZ Bank reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
DZ Bank sold 4,734 Jazz Pharmaceuticals shares in Q1 2026, an estimated $805K.
DZ Bank first reported a position in Jazz Pharmaceuticals in Q1 2018 and held it in 12 quarters.
DZ Bank's Jazz Pharmaceuticals position peaked at $15.3M in Q1 2024.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.